Physician

Aref Rifai, MD

According to 2025 Medicare claims, Aref Rifai, MD (NPI: 1265428270) practices ophthalmology in the Pensacola-Ferry Pass-Brent, FL market, with the plurality of this provider's patient population coming from Escambia, FL. This provider's primary affiliated billing organization is RETINA CENTER OF PENSACOLA PA (NPI: 1760810329; TIN: 463751697) and primary practice location at 32504-8634.

Rifai's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 939 traditional Medicare patients, billed 19,045 HCPCS/CPT codes, and received $1,429,175 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 1,929 prescription claims across 404 beneficiaries totaling $160,908 in drug costs, led by Restasis (Cyclosporine). Open Payments data shows 12 records totaling $618. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $852,152 to $1,429,175. Similarly, Part D prescription costs have risen steadily, from $101,392 to $160,908. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$715K$1.4M2015 Medicare payment: $852,152 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $900,975 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $834,924 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $738,179 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $765,112 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,021,275 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,090,559 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,086,356 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,064,196 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,429,175 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,20010,822$852,152
20161,23011,086$900,975
20171,21710,791$834,924
20181,1469,610$738,179
20191,1109,678$765,112
20201,0489,065$1,021,275
20211,0158,762$1,090,559
20229728,061$1,086,356
202393010,635$1,064,196
202493919,045$1,429,175

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$81K$162K2015 Drug cost: $101,392 (USD; Tot_Drug_Cst)2016 Drug cost: $106,204 (USD; Tot_Drug_Cst)2017 Drug cost: $125,625 (USD; Tot_Drug_Cst)2018 Drug cost: $121,123 (USD; Tot_Drug_Cst)2019 Drug cost: $115,344 (USD; Tot_Drug_Cst)2020 Drug cost: $148,438 (USD; Tot_Drug_Cst)2021 Drug cost: $138,419 (USD; Tot_Drug_Cst)2022 Drug cost: $157,685 (USD; Tot_Drug_Cst)2023 Drug cost: $162,294 (USD; Tot_Drug_Cst)2024 Drug cost: $160,908 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20153601,871$101,392
20163651,825$106,204
20173661,960$125,625
20183371,720$121,123
20193281,716$115,344
20203501,816$148,438
20213541,740$138,419
20223521,760$157,685
20233661,724$162,294
20244041,929$160,908

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
67028Injection of drug into eye2271,187$85
92014Established patient complete exam of visual system630887$82
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more2321,125$64
92134Imaging of retina7341,692$28
92250Photography of the retina143149$23

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RestasisCyclosporine191,410$28,500
RhopressaNetarsudil Mesylate391,978$22,153
LumiganBimatoprost301,747$15,200
CombiganBrimonidine Tartrate/Timolol231,785$12,728
RocklatanNetarsudil Mesylat/Latanoprost231,082$12,714

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.12$618Regeneron Healthcare Solutions, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Aref Rifai, MD?

Tedicare shows public-source Medicare data for Aref Rifai, MD (NPI 1265428270), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Aref Rifai, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Aref Rifai, MD?

Aref Rifai, MD is linked to RETINA CENTER OF PENSACOLA PA (billing NPI 1760810329) in the available physician profile data.

Does Aref Rifai, MD have Open Payments data?

Aref Rifai, MD has 12 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.